Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in Botswana
PURPOSEBreast cancer (BC) is the most common female cancer worldwide, and the burden is increasing across sub-Saharan Africa. For women with hormone receptor–positive (HR+) cancers, endocrine therapy (ET) taken for 5-10 years can reduce the risk of recurrence by half. We explored experiences with ET...
Saved in:
| Main Authors: | James R. Wester, Rachel B. Wagner, Bosa Motladiile, Isaac Nkele, Nkhabe Chinyepi, Moeketsi J. Makhema, Tara M. Friebel-Klingner, Peter Vuylsteke, Shahin Lockman, Scott Dryden-Peterson, Racquel E. Kohler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society of Clinical Oncology
2024-12-01
|
| Series: | JCO Global Oncology |
| Online Access: | https://ascopubs.org/doi/10.1200/GO.24.00180 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls.
by: Mosepele Mosepele, et al.
Published: (2017-01-01) -
Impact of the COVID-19 Pandemic on Cervical Cancer Treatment Delays in Botswana
by: Surbhi Grover, et al.
Published: (2025-05-01) -
A qualitative assessment of barriers to iron and folic acid supplementation among pregnant women in Botswana
by: Poloko Kebaabetswe, et al.
Published: (2024-12-01) -
Baseline Distress and Effectiveness of Survivor Video Narratives on Cancer-Associated Distress in Botswana: A Pilot Study
by: Yehoda M. Martei, et al.
Published: (2025-06-01) -
Correction: Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART.
by: Maureen Sakoi-Mosetlhi, et al.
Published: (2024-01-01)